Citi Downgrades NGM Biopharmaceuticals (NGM) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- Wall Street ends down as US-Iran peace optimism fades
- S&P 500 EPS growth above 20% is rare. Why 2027 may be at risk
- Goldman Sachs warns AI investment may be crowding out other business spending
- Why Wednesday's inflation print could provide the next dovish catalyst
- Tesla needs Robotaxi flywheel proof to boost investor conviction: Morgan Stanley
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Wall Street ends down as US-Iran peace optimism fades
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
Form SC 13D/A NGM BIOPHARMACEUTICALS Filed by: COLUMN GROUP L P
February 26, 2024 5:16 PM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
... MoreForm SC14D9C NGM BIOPHARMACEUTICALS Filed by: NGM BIOPHARMACEUTICALS INC
February 26, 2024 5:12 PM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
... MoreForm 8-K NGM BIOPHARMACEUTICALS For: Feb 25
February 26, 2024 5:02 PM ESTNGM BIOPHARMACEUTICALS INC false 0001426332 0001426332... More
Form SC TO-C NGM BIOPHARMACEUTICALS Filed by: COLUMN GROUP L P
February 26, 2024 4:56 PM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.... More
